枸杞多糖在抑制P.azotoformans中的应用
By using a drug for treating intestinal damage made from Lycium barbarum polysaccharides, the abundance of P. azotoformans was inhibited, thus resolving intestinal damage caused by immunodeficiency, improving gut microbiota and tissue structure, and enhancing intestinal function.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- NORTHWEST UNIV
- Filing Date
- 2023-12-07
- Publication Date
- 2026-07-17
AI Technical Summary
Existing technologies have failed to effectively address intestinal damage caused by immunodeficiency, particularly the problems of intestinal flora imbalance and tissue damage caused by Pseudomonas azotoformans.
Using Lycium barbarum polysaccharides, different components of Lycium barbarum polysaccharide aqueous solutions are prepared, and pharmaceutically acceptable excipients are added to make capsules, tablets, granules, injections, sustained-release preparations, oral liquids or drop pills, which are used to inhibit the increase of P. azotoformans abundance in the intestine and improve intestinal flora imbalance.
Lycium barbarum polysaccharides can significantly reduce the abundance of P. azotoformans in the intestines of immunodeficient mice, improve jejunal tissue morphology, enrich short-chain fatty acids, improve immune organ index and body weight, and alleviate intestinal damage caused by immunodeficiency.
Smart Images
Figure BDA0004594678520000051 
Figure BDA0004594678520000071 
Figure BDA0004594678520000081